TH and acute myeloid leukemia: The expression levels of nestin and TH in positive individuals were significantly decreased in AML patients compared with those in controls (nestin: 3.2±1.68 vs 3.85±1.43, P=0.047; TH: 1.15±1.31 vs 3.05±1.32, P=0.000).